Decision: Favourable

Decisions Table

Study Title:

A phase IIb, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet

  • NREC Code:

    21-NREC-CT-173

  • Decision:

    Favourable

  • Meeting Date:

    12/02/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Professor Valerie Byrnes

  • PI Institution:

    University Hospital Galway

  • Sponsor:

    Dr Falk. Pharma GmbH

Scroll to Top